United Therapeutics reported $100M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Ardelyx USD 251.82M 48.31M Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Bayer EUR 37.7B 6.54B Sep/2026
BioCryst Pharmaceuticals USD 395.61M 209K Sep/2026
Biogen USD 7.29B 1.7M Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Gilead Sciences USD 23.82B 17M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
Halozyme Therapeutics USD 2.94B 1.01B Sep/2026
Insmed USD 544.86M 1.35M Sep/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
J&J USD 35.8B 1.55B Sep/2026
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
Moderna USD 3.55B 2.95B Sep/2026
Omeros USD 403.72M 27.2M Jun/2024
Pfizer USD 60B 498M Sep/2026
PTC Therapeutics USD 536.27M 749K Sep/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 3.5B 3.39B Sep/2026